Clinical and prognostic characteristics of <I>BRCA1/2</I>-associated breast cancer depending on the type of mutation: estrogen signaling pathway and secondary tumors

• Main Authors: A. I. Stukan (Author), A. Yu. Goryainova (Author), R. A. Murashko (Author), Z. K. Khachmamuk (Author), O. Yu. Chukhray (Author), S. D. Maksimenko (Author), O. A. Goncharova (Author), E. N. Imyanitov (Author), V. A. Porkhanov (Author)
• Format: Book
• Published: ABV-press, 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background. Currently, there is growth evidence on prognostic and clinical differences in breast cancer (BC) associated with different types of BRCA1 / 2 mutations. At the same time, a triple negative tumor phenotype is not an absolute pathognomonic sign of BRCA1 / 2-associated cancer, where luminal...